• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now

    10/31/23 7:00:00 AM ET
    $AGBA
    $AMPE
    $CING
    $COCH
    Investment Managers
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGBA alert in real time by email

    MIAMI, Oct. 31, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 64th Emerging Growth Conference on November 1st and 2nd, 2023.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1

    November 1, 2023

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 - 9:35

    AGBA Group Holding Limited (NASDAQ:AGBA)

    Keynote speaker: Mr. Wing-Fai Ng, Group President of AGBA Group

    9:40 - 10:10

    Battery Mineral Resources Corp., (OTCQB:BTRMF) (TSXV:BMR)

    KeKeynote speaker: Martin Kostuik, President / CEO

    10:15 - 10:45

    Envoy Medical, Inc. (NASDAQ:COCH)

    Keynote speaker: Brent Lucas, CEO & David R. Wells, CFO

    10:50 - 11:20

    Houston Natural Resources Corp. (OTC:HNRC)

    Keynote speaker: Frank Kristan, Chairman & CEO

    11:25 - 11:55

    Electronic Servitor Publication Network Inc. (OTCQB:XESP)

    Keynote speaker: Peter Hager, President / CEO

    12:00 - 12:30

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    12:35 - 1:05

    Ocean Biomedical, Inc. (NASDAQ:OCEA)

    Keynote speakers:

    Dr. Chirinjeev Kathuria, Co-founder / Chairman,

    Elizebeth Ng, CEO,

    Dr. Jonathan Kurtis, Scientific Co-founder & Director of the MD/PhD program Brown University,

    Gurinder Kalra, CFO,

    Daniel Behr, EVP of Academic Partnerships,

    Dr. Inderjote Kathuria, Chief Strategy Officer

    1:10 - 1:40

    GPO Plus, Inc. (OTCQB:GPOX)

    Keynote speaker: Brett Pojunis, President / CEO

    Postponed to December 6

    Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP)

    Keynote speaker: David Mehalick, President / CEO

    2:20 - 2:50

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO & Harry M. Lander, Ph.D. Senior Scientific Consultant

    2:55 - 3:05

    Renforth Resources, Inc. (OTCQB:RFHRF) (CSE:RFR)

    Keynote speaker: Nicole Brewster, President & CEO

    3:10 - 3:20

    Ideal Power (NASDAQ:IPWR)

    Keynote speaker: Dan Brdar, President / CEO, & Tim Burns, CFO

    3:25 - 3:35

    Steppe Gold, Ltd. (OTCQX:STPGF) (TSX:STGO)

    Keynote speakers: Aneel Singh, Exec. VP & Director

    3:40 - 3:50

    NeuroMetrix, Inc. (NASDAQ:NURO)

    Keynote speaker: Dr. Shai Gozani, CEO & Thomas Higgins, CFO

    3:55 - 4:05

    RedCloud Technologies, a Private Company

    Keynote speaker: Justin Floyd, CEO

    Day 2

    November 2, 2023

    10:00

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:35

    Introduction

    10:15 - 10:45

    Sonim Technologies, Inc. (NASDAQ:SONM)

    Keynote speaker: Hao Liu, CEO

    10:50 - 11:20

    Quantum Computing Inc., (NASDAQ:QUBT)

    Keynote speakers: Robert Liscouski, CEO, & Chris Boehmler, CFO

    11:25 - 11:55

    Gold Terra Resource Corp. (OTCQX:YGTFF) (TSXV:YGT)

    Keynote speaker: Gerald Sylvain Panneton, CEO

    12:00 - 12:30

    Independence Contract Drilling, Inc. (NYSE:ICD)

    Keynote speaker: Anthony Gallegos, President / CEO & Director

    12:35 - 1:05

    BioHarvest Sciences Inc. (OTCQB:CNVCF) (CSE:BHSC)

    Keynote speaker: Ilan Sobel, CEO

    1:10 - 1:40

    Ampio Pharmaceuticals, Inc. (NYSE:AMPE)

    Keynote speaker: Michael Martino, CEO & Director

    1:45 - 2:15

    Medicus Pharma Ltd. (TSXV:MDCX)

    Keynote speaker: Carolyn Bonner, President

    Postponed to December 6

    Cingulate Inc. (NASDAQ:CING)

    Keynote speaker: Shane Schaffer, CEO

    2:55 - 3:05

    Loop Industries, Inc. (NASDAQ:LOOP)

    Keynote speaker: Kevin C. O'Dowd, VP Communications

    3:10 - 3:20

    Theriva Biologics Inc., (NYSE:TOVX)

    Keynote speaker: Dr. Manel Cascallo', General Director

    3:25 - 3:35

    Alpha Tau Medical, Inc. (NASDAQ:DRTS)

    eynote speaker: Raphi Levy, CFO

    3:55 - 4:05

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speaker: David Dodd, Chairman, President / CEO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $AGBA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGBA
    $AMPE
    $CING
    $COCH

    CompanyDatePrice TargetRatingAnalyst
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Quantum Computing Inc.
    $QUBT
    1/15/2026$22.00Buy
    Rosenblatt
    Quantum Computing Inc.
    $QUBT
    12/17/2025$12.00Neutral
    Wedbush
    Quantum Computing Inc.
    $QUBT
    9/18/2025$24.00Buy
    Lake Street
    Quantum Computing Inc.
    $QUBT
    7/2/2025$15.00Neutral
    Cantor Fitzgerald
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$15.00 → $8.50Buy
    Alliance Global Partners
    Cingulate Inc.
    $CING
    1/10/2025$12.00Buy
    ROTH MKM
    More analyst ratings

    $AGBA
    $AMPE
    $CING
    $COCH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rosenblatt initiated coverage on Quantum Computing with a new price target

    Rosenblatt initiated coverage of Quantum Computing with a rating of Buy and set a new price target of $22.00

    1/15/26 8:40:11 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Wedbush initiated coverage on Quantum Computing with a new price target

    Wedbush initiated coverage of Quantum Computing with a rating of Neutral and set a new price target of $12.00

    12/17/25 9:27:03 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    $AGBA
    $AMPE
    $CING
    $COCH
    SEC Filings

    View All

    SEC Form 424B5 filed by Ideal Power Inc.

    424B5 - Ideal Power Inc. (0001507957) (Filer)

    2/25/26 9:25:28 AM ET
    $IPWR
    Semiconductors
    Technology

    SEC Form 6-K filed by Alpha Tau Medical Ltd.

    6-K - Alpha Tau Medical Ltd. (0001871321) (Filer)

    2/24/26 9:01:57 AM ET
    $DRTS
    Medical/Dental Instruments
    Health Care

    SEC Form 424B5 filed by Ideal Power Inc.

    424B5 - Ideal Power Inc. (0001507957) (Filer)

    2/23/26 4:21:05 PM ET
    $IPWR
    Semiconductors
    Technology

    $AGBA
    $AMPE
    $CING
    $COCH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ideal Power Business Update Webcast Call on February 26, 2026

    AUSTIN, Texas, Feb. 24, 2026 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch, today announced management will conduct a business update webcast call on February 26, 2026 at 1:00 PM ET. The webinar will be led by David Somo, Chief Executive Officer, President, and Board Member of Ideal Power.There will be an allotted time for equity research analysts and investors to ask questions during the live conference call on February 26. Additionally, questions can be submitted HERE in advance of the conference call.Interested persons may acce

    2/24/26 4:28:00 PM ET
    $IPWR
    Semiconductors
    Technology

    Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer

    - Approval establishes first clinical authorization outside Israel and initiates post-market surveillance program - - First-in-kind technology delivers intra-tumoral alpha-emitting radiotherapeutics, reflects strength of clinical data and strong collaboration with Japanese regulators and clinical societies - JERUSALEM, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ:DRTS, DRTSW)) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that Japan's Ministry of Health, Labour and Welfare ("MHLW") has granted regulatory (Shonin) marketing approval for Alpha DaRT for the treatment of unresectable locally advanced or locally

    2/24/26 9:00:00 AM ET
    $DRTS
    Medical/Dental Instruments
    Health Care

    Quantum Computing Inc. to Host Fourth Quarter And Full Year 2025 Shareholder Call on Monday, March 2, 2026

    HOBOKEN, N.J., Feb. 24, 2026 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (NASDAQ:QUBT), an innovative, integrated photonics and quantum optics technology company, today announced that the Company will host a conference call and webcast on Monday, March 2, 2026 at 4:30 p.m. Eastern Time to review the Company's operational progress for the fourth quarter and year ended December 31, 2025. The Company will release its fourth quarter and year end 2025 financial results that day after the market closes. To access the live webcast of the conference call, visit the QCi Investor Relations page at https://quantumcomputinginc.com/investor-relations. Investors may also access the web

    2/24/26 8:30:00 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    $AGBA
    $AMPE
    $CING
    $COCH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Patel Mona Chetan bought $125,000 worth of shares (312,500 units at $0.40), increasing direct ownership by 1,562% to 332,500 units (SEC Form 4)

    4 - Envoy Medical, Inc. (0001840877) (Issuer)

    2/17/26 4:51:51 PM ET
    $COCH
    Industrial Specialties
    Health Care

    Interim CFO Potashnick Robert bought $85,000 worth of shares (212,500 units at $0.40) (SEC Form 4)

    4 - Envoy Medical, Inc. (0001840877) (Issuer)

    2/17/26 4:49:33 PM ET
    $COCH
    Industrial Specialties
    Health Care

    Director Kantor Susan bought $38,460 worth of shares (96,150 units at $0.40), increasing direct ownership by 123% to 174,037 units (SEC Form 4)

    4 - Envoy Medical, Inc. (0001840877) (Issuer)

    2/17/26 4:47:12 PM ET
    $COCH
    Industrial Specialties
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Dna Holdings Venture Inc. claimed ownership of 223,201 shares (SEC Form 3)

    3 - DNA X, Inc. (0001178697) (Issuer)

    2/20/26 4:30:26 PM ET
    $SONM
    Telecommunications Equipment
    Utilities

    Director Patel Mona Chetan bought $125,000 worth of shares (312,500 units at $0.40), increasing direct ownership by 1,562% to 332,500 units (SEC Form 4)

    4 - Envoy Medical, Inc. (0001840877) (Issuer)

    2/17/26 4:51:51 PM ET
    $COCH
    Industrial Specialties
    Health Care

    Interim CFO Potashnick Robert bought $85,000 worth of shares (212,500 units at $0.40) (SEC Form 4)

    4 - Envoy Medical, Inc. (0001840877) (Issuer)

    2/17/26 4:49:33 PM ET
    $COCH
    Industrial Specialties
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    Financials

    Live finance-specific insights

    View All

    Ideal Power Business Update Webcast Call on February 26, 2026

    AUSTIN, Texas, Feb. 24, 2026 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch, today announced management will conduct a business update webcast call on February 26, 2026 at 1:00 PM ET. The webinar will be led by David Somo, Chief Executive Officer, President, and Board Member of Ideal Power.There will be an allotted time for equity research analysts and investors to ask questions during the live conference call on February 26. Additionally, questions can be submitted HERE in advance of the conference call.Interested persons may acce

    2/24/26 4:28:00 PM ET
    $IPWR
    Semiconductors
    Technology

    Quantum Computing Inc. to Host Fourth Quarter And Full Year 2025 Shareholder Call on Monday, March 2, 2026

    HOBOKEN, N.J., Feb. 24, 2026 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (NASDAQ:QUBT), an innovative, integrated photonics and quantum optics technology company, today announced that the Company will host a conference call and webcast on Monday, March 2, 2026 at 4:30 p.m. Eastern Time to review the Company's operational progress for the fourth quarter and year ended December 31, 2025. The Company will release its fourth quarter and year end 2025 financial results that day after the market closes. To access the live webcast of the conference call, visit the QCi Investor Relations page at https://quantumcomputinginc.com/investor-relations. Investors may also access the web

    2/24/26 8:30:00 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Quantum Speed Technology Targeting Multi-Trillion-Dollar Infrastructure Efficiency Opportunity

    Advanced computing power positions companies to unlock cost savings across global energy, transportation, and logistics networksNEW YORK, Feb. 17, 2026 /CNW/ -- Market News Updates News Commentary - Quantum speed is all about solving really big problems much faster than traditional computers. For large-scale infrastructure -- think power grids, transportation systems, or supply chains -- there are millions of data points and interconnected moving parts. Classical computers can tackle this complexity, but it often takes a long time. Quantum-powered systems, by contrast, can evaluate many possibilities at once, helping planners and operators find smarter solutions in a fraction of the time. Th

    2/17/26 9:00:00 AM ET
    $IONQ
    $LAZR
    $QBTS
    EDP Services
    Technology
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AGBA
    $AMPE
    $CING
    $COCH
    Leadership Updates

    Live Leadership Updates

    View All

    Quantum Computing Inc. Confirms Dr. Yuping Huang as Chief Executive Officer to Lead Global Growth

    HOBOKEN, N.J., Dec. 17, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (NASDAQ:QUBT), an innovative, quantum optics and integrated photonics technology company, today announced a leadership update with the appointment of Dr. Yuping Huang as Chief Executive Officer ("CEO"), effective January 1st, 2026. Dr. Huang was appointed as QCi's Interim CEO on April 11, 2025. This appointment comes as part of QCi's ongoing focus on growth and scaling its quantum photonics systems for industrial and commercial use. Dr. Huang's appointment marks a pivotal moment as QCi moves from prototype development and small-batch manufacturing toward industrial-scale manufacturing production. The

    12/17/25 8:30:00 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

    Industry Veteran Bryan Downey Named Chief Commercial Officer NDA Accepted with May 2026 PDUFA Date Commercial Supply Agreement Executed KANSAS CITY, Kan., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to build a pipeline of next-generation products, today announced financial results for the quarter ended September 30, 2025, and provided recent corporate highlights. Recent Highlights (Post-Q3) FDA Accepts NDA for CTx-1301; PDUFA Date Set for May 31, 2026In October of 2025, the U.S. Food and Drug Administration (FDA) accepted Cingulate's New Drug Application

    11/13/25 8:00:00 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation for CTx-1301

    Appointment builds on recent FDA acceptance of New Drug Application for review and advances Cingulate's transition toward commercialization pending FDA approval Company also strengthens its cash position by completing a $6 million financing KANSAS CITY, Kan., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing its proprietary Precision Timed Release™ (PTR™) drug-delivery platform, today announced the appointment of Bryan Downey as Chief Commercial Officer, following the U.S. Food and Drug Administration's (FDA) acceptance of Cingulate's New Drug Application (ND

    11/10/25 8:00:00 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cingulate Inc.

    SC 13G/A - Cingulate Inc. (0001862150) (Subject)

    11/14/24 7:21:05 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by GeoVax Labs Inc.

    SC 13G/A - GeoVax Labs, Inc. (0000832489) (Subject)

    11/14/24 5:10:48 PM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Coeptis Therapeutics Holdings Inc.

    SC 13G/A - Coeptis Therapeutics Holdings, Inc. (0001759186) (Subject)

    11/14/24 3:59:49 PM ET
    $COEP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care